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Summary 
Examination of the extracellular products of nephritis(+) and nephritis(-) group A streptococci 
revealed the presence of a 46-kD protein secreted by nephritogenic strains that binds to human 
plasmin. Immunological data revealed that this protein, called nephritis plasmin binding protein 
(NPBP),  is  not  related to  group  A  streptokinase  nor  to  a  recently described streptococcal 
dehydrogenase protein. The binding of human plasmin to this protein can be blocked by e-amino 
caproic acid, indicating the importance of lysine groups in the binding process.  Mutanolysin 
extracts of cell walls from these nephritogenic strains probed with anti-NPBP antibody were 
negative for cell wall-bound NPBP. Serological data with acute poststreptococcal glomerulonephritis 
(APSGN) and acute rheumatic fever sera indicated that the protein reacts preferentially with 
APSGN sera. Amino acid sequence analysis and immunological reactivity suggest NPBP is the 
streptococcal pyrogenic exotoxin B precursor, also previously described as zymogen (streptococcal 
proteinase precursor). The secretion of both group A streptokinase and a secreted plasmin binding 
protein in the same nephritogenic strain raises an intriguing hypothesis of the mechanism of 
action of this protein in APSGN. 
I 
nvestigations spanning several decades have revealed that 
only certain strains of group A streptococci (1) are capable of 
causing acute poststreptococcal glomerulonephritis (APSGN). 
The acute onset of the disease coupled with the fact that "skin" 
or impetigo nephritis produces a disease identical in all respects 
to "throat" nephritis has suggested that nephritogenic strep- 
tococci might secrete a product unique to those streptococcal 
strains associated with nephritis. 
Previous work in our laboratory has identified two extracel- 
lular  products,  called  nephritis  strain-associated  protein 
(NSAP) and group A streptokinase, of similar molecular mass 
that are preferentially secreted by nephritogenic streptococci 
(2, 3). While NSAP was identified in 18 of 21 APSGN biop- 
sies and reacted only with the sera of APSGN patients, strep- 
tokinase was not localized in 10 APSGN biopsies.  Further- 
more,  streptokinase did not react uniquely with APSGN 
sera (4). 
In view of the discrepancies noted above, we reexamined 
the question of what are the biological activities of the pro- 
tein we have called NSAP. The reports by Lottenberg et al. 
and Broder et al. (5, 6), that a streptococcal cell wall plasmin 
receptor protein had plasmin binding properties and had ap- 
proximately the same molecular mass as NSAP, prompted 
us to examine the extracellular products (ECP) of nephrito- 
genic streptococci for a plasmin binding protein. 
The present report demonstrates that the extraceUular prod- 
ucts of all nephritis-associated streptococci tested secrete a 
plasmin binding protein not seen in nonnephritogenic strep- 
tococci. The size of this protein (46,000 daltons) is similar 
to that previously described for NSAP (2), and immunolog- 
ical and structural data confirm that it is not group A strep- 
tokinase. 
Materials  and Methods 
Streptococcal Strains.  All streptococcal strains were from The 
Rockefeller University coUection and were part of the group of 
strains used in previous studies of APSGN (2, 3). Nephritis (+): 
F203d (type 1), A374 (type 12), B923 (type 12), A207 (type 2), 
B905 (type 4), and B512 (type 3). Nephritis (-): A456 (type 36), 
A830 (type 3), A990 (type 4), 1GL22 (type 30), 1GL22 (type 30), 
1GL362 (type 19), and A834 (type 49). Nephritogenic strains were 
defined  as those strains isolated directly from a patient with APSGN 
while the other strains were not associated  with known nephritis. 
Isolation of  ECP.  The method ofisohtion of ECP for each strain 
was carried out essentially  as previously  described  0) with the minor 
modification of adding 10% dialyzed Todd Hewitt medium (pep- 
tides <10,000 daltons) to the chemically defined medium for better 
growth. The ECP of all strains were adjusted to the same total 
protein concentration before use. 
SDS-PAGE.  All electrophoretic analyses were carried out ac- 
cording to the procedure of Laemmli (7) using 10% SDS gels. 
Immunoblots.  All ECP were immunoblotted using the proce- 
dure of Towbin et al. (8). The signal antibody, alkaline phospha- 
tase-conjugated F(ab)2 goat anti-rabbit serum, was diluted 1:1,000 
(Tago, Inc., Burlingame, CA). 
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paper, containing the transferred ECP of the various  strains,  was 
first blocked for 2 h in 10 mM Tris, 0.5% Tween, 1% crystalline 
BSA, pH 8.2, and then probed as follows:  the paper was bathed 
in a solution containing human plasmin at 20 ng/ml (Sigma Chem- 
ical Co., St. Louis, MO),  1% BSA, 0.5% Tween, 0.04% sodium 
azide, pH 7.0, plus added PMSF (2 raM) for 18 h at room tempera- 
ture.  After several washes  in blocking buffer to remove residual 
plasmin, the paper was probed with a rabbit anti-human plasmin 
IgG F(ab)2 preparation at 1:100 dilution for 90 min at room tem- 
perature. After repeated washes in blocking buffer,  the paper was 
exposed to the alkaline  phosphatase-conjugated goat anti-rabbit 
F(ab)2 antibody (1:1,000) for an additional 1 h and then developed 
with alkaline phosphatase  substrate (Sigma Chemical Co.). Appro- 
priate controls included preimmune rabbit serum, signal antibody 
alone,  and first  antibody without plasmin. 
Human Sera.  Human sera were obtained from The Rockefeller 
University collection. Sera from well-documented acute rheumatic 
fever (ARF) and APSGN patients were used.  Controls were age 
matched and were obtained from the same geographical area as 
the patient  sera. 
AnimalSera.  To obtain antiserum specific for human plasmin, 
rabbits were immunized with commercially available  human phsmin 
(Sigma  Chemical Co.) at a concentration of 1 mg/ml in incom- 
plete adjuvant X2 ,,o 1 mo apart.  Serum was collected 10 d after 
the second injection and used at a 1:5,000 dilution. In some experi- 
ments,  pepsin-digested  antibody, F(Ab)2,  of these sera was used 
at a dilution of 1:100. 
For the production of antibody to the NPBP, the pure protein 
band was  identified on SDS-PAGE gels.  The gel slices were cut 
out, lyophilized, pulverized, taken up in a small volume of PBS, 
and used for immunization of rabbits at 3-wk intervals.  10 d after 
the third immunization, animals were bled and tested for reactivity 
to the binding protein in  immunoblots.  The whole serum was 
diluted  1:4,000  for  most  experiments.  A  F(ab)2 IgG  fraction 
diluted 1:100 was  used in some experiments. 
Rabbit polyclonal antibodies to streptococcal proteinase zymogen 
as well as  streptococcal pyrogenic toxin B  (SPEB) were kindly 
provided by Drs. Liu (Center for Biologics Evaluation and Research, 
FDA, Bethesda, MD) and Ferretti (University of  Oklahoma), respec- 
tively 
Cell WallExtractions.  Mutanolysin extraction of the nephritic(+) 
strains  was carried out according to method of Lottenberg et al. 
(5).  After extraction, the suspension  was centrifuged for 10 min 
at  10,000 g  and the supernatants of each strain  were adjusted  to 
same protein concentration. 
Purification of NPBP.  The dialyzed ECP (0.05  M Tris buffer, 
pH 8.4) of strain F203D was applied to a DEAE column and eluted 
stepwise  with 0.1-, 0.3-, and 0.5-M NaC1 gradients.  The 0.1-M 
fraction containing the protein was dialyzed in 0.05 M Tris buffer 
(pH 9.5) and applied  to a FPLC Mono Q  column. The fractions 
containing the protein were combined, concentrated, and further 
purified to homogeneity by passage through a FPLC Superose  12 
column. SDS-PAGE and immunoblots were used to monitor the 
purification and eventual purity of the preparation. 
Purification of  Grou  F A Streptokinase.  Group A streptokinase was 
purified as previously described (3). The purified material was used 
at  100 #g/ml and 10 #1 of the material was  added to each  lane 
in the SDS-PAGE gels. 
Protein Sequence Studies.  The purified NPBP was run on a 10% 
SDS-PAGE gel transferred to PVDF Immobilon-P membrane (Mil- 
lipore Corp., Bedford, MA), and the strip cut out after identification 
of the pure protein by Coomassie stain and immunoblot. The strip 
containing the NPBP protein was sent to The Rockefeller Univer- 
sity sequencing facilities for NHz-terminal amino acid analysis. 
E-Amino-Caproic  Acid(EACA) Studies.  The purified NPBP ma- 
terial was run on a 10% SDS-PAGE,  transferred to nitrocellulose 
paper, and cut into strips to which decreasing dilutions of the EACA 
solution (Sigma Chemical Co.) starting at 0.5-M concentration were 
added.  The strips were then probed with the standard concentra- 
tion of plasmin followed by the addition of the antiplasmin anti- 
body as described  above. 
Results 
Comparable aliquots (300/xg/ml) of the concentrated dia- 
lyzed ECP from nephritogenic and nonnephritogenic strains 
were run on SDS gels and stained with Coomassie blue (Fig. 
1).  As can be seen (arrows) a protein appears at 46 kD in all 
six nephritogenic ECP that is not seen in the six nonnephrito- 
genic ECP.  While the general ECP gel patterns differed ex- 
tensively between nephritogenic and nonnephritogenic strains, 
the 46-kD protein was consistently present in all nephrito- 
genic  strains. 
Immunoblots of the ECP from eight strains were used to 
determine the plasmin binding capacity of the proteins.  As 
seen in Fig.  2 A,  a distinct band appears at 46 kD only in 
the  ECP  of nephritogenic  streptococci (lanes  I-4).  Using 
similar immunoblots with antisera to streptokinase, the lower 
bands seen in lanes 2 and 3, which also bound plasmin, were 
clearly identified  as  streptokinase,  a  finding  also  noted by 
Broder et  al.  (6)  in  their  studies. 
To verify the presence of the NPBP in only the ECP of 
Figure  1.  SDS-PAGE  gels of the ECP of six nephritogenic(+) and six 
nonnephritogenic(- ) strains. The arrows denote the presence  of a protein 
band of 46 kD seen only in the nephritis(+) strains. All ECP were ad- 
justed to a protein concentration of 300/~g/ml, and 6 ~g of protein was 
loaded in each  lane. Molecular  mass markers (kD) are depicted  on the left. 
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strains were transferred  to nitrocellulose  paper and probed with 20 ng/ml 
of human plasmin for 24 h. After washing, the paper was probed with 
rabbit anti-human plasmin antibody followed  by signal antibody and sub- 
strate. Note the presence of a positive band in the ECP of nephritis(+) 
strains (lanes I-4) and the absence of these bands in nonnephritic ECP 
(lanes 5-8).  The lower bands in lanes 2 and 3 were identified as strep- 
tokinase using monoclonal and polyclonal antibodies to group A strep- 
tokinase (data not shown). Lane I, A207; lane 2, B512; lane 3, B923; 
lane 4, F203D; lane 5, A990; lane 6, A834; lane 7, A830; lane 8; A456. 
(/3) The ECP of the same strains used as in A were transferred  to nitrocel- 
lulose and probed with rabbit antibody to purified NPBP followed  by the 
appropriate signal antibody.  Lanes  I-4 represent  ECP of  nephritis(+) strains, 
while lanes 4-8 represent the ECP of the nephritis(-) strains. Note the 
presence of the band at 46 kD only in the ECP of nephritis(+) strains. 
Lane 1, A374; lane 2, F203D; lane 3, A207; lane 4, B923; lane 5, A990; 
lane 6, A834; lane 7, A830; lane 8; A456. In both experiments preim- 
mune sera from rabbits as well as the signal antibody alone were negative. 
nephritogenic strains, immunoblots were probed with anti- 
body prepared against the purified NPBP.  Fig.  2 B  demon- 
strates that only the ECP of nephritic strains contain the NPBP 
and it is the same protein to which human plasmin bound 
(see Fig.  2 A).  To determine whether lysine groups played 
an important role in the binding ofplasmin to NPBP (a finding 
noted by Broeseker et al. [9] in their studies of the cell wall 
plasmin receptor protein), varying concentrations of EACA 
were added to immunoblot  strips of transferred NPBP be- 
fore the addition of human plasmin. Concentrations of EACA 
as low as 1.0 mM effectively blocked the binding of human 
plasmin  to  NPBP  (data  not  shown). 
To be sure that NPBP was neither group A  streptokinase 
(similar  molecular  mass)  nor  the  streptococcal  surface de- 
hydrogenase (SDH) proteins recently described by Pancholi 
and Fischetti (10) and Lottenberg et al.  (11),  immunoblots 
using purified NPBP were probed with the appropriate anti- 
bodies. Fig. 3 A  demonstrates that antibody to NPBP reacts 
specifically with purified antigen (lane 1). In contrast, poly- 
clonal  and  monoclonal  antibodies  prepared  against  strep- 
tokinase (lanes 2 and 3) were negative. Similar negative results 
were obtained when  antibody  to SDH  (lane 4)  was  used. 
Using a Western blot with purified streptokinase (Fig. 3 
B),  the converse was  also  true.  Antibody  to SDH  did not 
bind to group A streptokinase (lane I), while both polyclonal 
and monoclonal antibodies bound to purified streptokinase 
(lanes 2 and 3). Finally, NPBP antibody did not bind to group 
A  streptokinase  (lane 4). 
The NPBP protein eluted from SDS gels was transferred 
to nitrocellulose paper and probed with APSGN, ARF, and 
normal  sera.  Only  APSGN  sera  recognized  the  plasmin 
binding protein when compared with AtLF and normal sera 
(see Fig.  4). 
The NHz-terminal sequence of the NPBP was determined 
from a PVDF membrane (Millipore Co., Bedford, MA) con- 
taining the transferred protein. No sequence similarities were 
found  with  previously characterized  streptococcal plasmin 
binding  proteins,  streptokinase  (3),  SDH  (10),  or the  cell 
wall-bound  plasmin  receptor protein described by Lotten- 
berg et al.  (11). Comparisons of the NPBP peptide sequence 
with  the Swissprotein  data base  showed complete identity 
with a region from the NH2 terminus of streptococcal pyro- 
genic exotoxin B  (SPEB)  precursor  (Fig.  5). 
Figure 3.  (A) Immunoblots of  purified  NPBP probed with various  an- 
tibodies. Lane I probed with rabbit anti-NPBP antibody (kindly provided 
by Dr. Pancholi, The Rockefeller  University); lanes 2 and 3, polyclonat 
and monoclonal antibodies to group A streptokinase; lane 4, probed with 
anti-SDH antibody (kindly provided by Dr. Pancholi). Note the positive 
reaction only in lane I. (B) Immunoblots of  group A streptokinase  probed 
with various antibodies. Lane 1 is anti-SDH antibody; lanes 2 and 3 are 
monoclonal and polyclonal antibodies to group A streptokinase, respec- 
tively: lane 4 was probed with anti-NPBP antibody. Note positive reac- 
tions only in lanes  2 and 3 with antibodies  specific  for group A streptokinase. 
Figure 4.  Immunoblots of nitrocellulose  paper transfer of 10% SDS- 
PAGE gels of purified NPBP probed with various human sera. Lanes 1 
and 2 are ARF sera; lanes  3-6 are APSGN sera; lanes 7-8 are normal sera. 
Note a strong band of reaction with NPBP in all four APSGN sera lanes. 
All human sera were used at a 1:1,000 dilution. 
NPBP  QNFARNEKEAKDSAITFIQKSAAI KAGAR 
8PB  B  MNKKKLGIRLLSLLALGGFVLANPVFADQNFARNEKEAKDSAITFIQKSAAIKAGARSAE 
i0  20  30  40  50  60 
Figure  5.  NH2-terminal amino acid sequence of NPBP aligned with 
the  NHz  terminus of streptococcal pyrogenic exotoxin B  (SPE  B) 
precursor. 
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probed with our anti-NPBP,  as well as antibody to SPEB, 
and the antizymogen antibody revealed identical bands, thus 
confirming the structural data (Fig.  6 A). 
Liu and Elliot (12) reported that streptococcal zymogen 
can be converted to active proteolytic form by treatment with 
the reducing agent dithiothreitol (DTT). To test for this ac- 
tivity,  NPBP and purified zymogen (a gift from Dr.  Liu) 
were treated for 2 h at 37~  in 0.5 mM DTT.  After SDS- 
PAGE of the DTT-treated proteins, immunoblots stained with 
anti-SPEB identified showed that both zymogen and NPBP 
preparations were sensitive to the DTT treatment, as revealed 
by a change in their electrophoretic migration (Fig.  6 B). 
However, neither the reduced zymogen nor NPBP exhibited 
proteolytic activity (data not shown). 
Finally,  to determine whether nephritogenic streptococci 
contained NPBP on the cell surface of the nephritogenic strains 
similar to that described by Lottenberg et al.  (5), Western 
blots of mutanolysin-extracted  cell walls were examined. Using 
the NPBP antibody as an immunological probe, none of the 
strains known to secrete NPBP contained a similar molecule 
in  the cell wall extracts (data not  shown). 
Discussion 
When our results were compared with those reported by 
Lottenberg et al. (5) and Broder et al. (6), several important 
differences  were noted. Their plasmin binding protein is a 
cell wall-associated protein of 41.8 kD and was found in all 
20 random group A streptococcal strains tested (5).  In con- 
trast,  our  plasmin  binding  protein  was  secreted into  the 
medium and was found only in the ECP of nephritogenic 
streptococci. Furthermore, our NPBP was 46 kD in contrast 
to the 41.8  kD described by them (5).  Finally,  the amino 
Figure 6.  (A) Immunoblots of zymogen (hnes a) and purified NPBP 
(lanes b) probed with anti-NPBP (/),  antizymogen (I/),  and anti-SPEB 
(111) antibodies. Note the presence of identical bands on immunoblots of 
SPEB, proteinase  zymogen, and NPBP when probed with the three diffeg~nt 
antibodies. (B) Immunoblot  of NPBP and zymogen showing the change 
in electrophoretic mobility after DTT treatment. Lane 1, zymogen in- 
cubated for 2 h at 37~  in reaction buffer (0.05 M Tris-HC1, pH 7.0); 
lane 2, zymogen incubated in reaction buffer with 0.5 mM DTT; lane 
3, NPBP incubated in reaction buffer; lane 4, NPBP incubated in reaction 
buffer with 0.5 mM DTT. 
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acid analysis of their protein (11) and the one described by 
Pancholi and Fischetti (10) reveal extensive homology with 
glyceraldehyde-3-phosphate  dehydrogenase  while our protein 
does not. Further studies by Broder et al. (6), using one strep- 
tococcal  strain,  demonstrated  that  their  protein  was  not 
secreted into the extracellular medium whereas the group A 
streptokinase secreted by that strain exhibited strong plasmin 
binding activity. 
In confirmation of the structural data, immunoblots with 
appropriate antisera revealed that our 46-kD protein was an- 
tigenically distinct from both group A streptokinase and an 
SDH protein recently described by Pancholi and Fischetti (10), 
which also exhibits plasmin binding activity. SDH has the 
identical NH2-terminal sequence of the plasmin binding pro- 
tein reported by Lottenberg et al. (11). The NPBP reported 
here was also found to react with antibodies found only in 
APSGN sera (see Fig. 4), a finding not seen in immunoblots 
with group A  streptokinase (4). 
Whether this protein is in reality the NSAP originally de- 
scribed by Villarreal  et al.  (2) remains unclear. The molec- 
ular mass of our protein is similar to the 47-kD protein de- 
scribed previously by Villarreal  et al. (2), and its preferential 
reactivity with APSGN sera is also  similar.  Unfortunately, 
antiserum prepared against NSAP is no longer available for 
direct comparisons. Future studies will determine whether 
this protein is also localized in the glomeruli of APSGN pa- 
tients, similar to the studies described by Villarreal et al. (2). 
An interesting and potentially important biological ob- 
servation was the experiment by Lottenberg et al. (13) demon- 
strating that the active plasmin, once bound to the cell wall 
receptor protein, was not inactivated by o~-2 antiplasmin, a 
physiological inhibitor of plasmin present in all human sera. 
Further studies by this group demonstrated that EACA at 
a concentration of 0.15 mM effectively blocked the binding 
of plasmin to its cell wall receptor, indicating the importance 
of lysine groups in the binding reaction (9).  Similar experi- 
ments were carried out with our protein. Using varying con- 
centrations of EACA, our results indicate that 1.0-mM con- 
centrations of EACA totally blocked the binding of plasmin 
to NPBP  in immunoblots. 
The amino acid sequence of NPBP suggests this protein 
is  the precursor of SPEB. Properties of this  toxin include 
pyrogenicity and skin rash production, and it is a potent V~- 
specific T cell mitogen with properties of a superantigen (14). 
The amino acid sequence encoded by the SPEB  structural 
gene has been shown to be very similar to the protein se- 
quence described for the streptococcal proteinase precursor 
(15). It is now believed that the streptococcal proteinase, ini- 
tially described by Liu and Elliot (12), and SPEB result from 
allelic variations of the same gene. 
This study suggests a third activity for this protein through 
its ability to bind human plasmin.  Through this function 
it may contribute in another way to the virulence of group 
A  streptococci.  The fact that  the same strains  secreting a 
plasmin binding protein concomitantly secrete group A strep- 
tokinase (3) raises an intriguing hypothesis concerning the 
pathogenic mechanisms whereby nephritogenic streptococci 
might initiate tissue destruction. Once in the tissues  of the 
ExtraceUular Plasmin Binding Protein from Nephritogenic  Streptococci susceptible host, group A streptokinase, known to be secreted 
by all nephritogenic strains,  converts human plasminogen to 
the active plasmin moiety. The activated plasmin then binds 
to the plasmin binding molecule also secreted by the same 
nephritogenic strain.  This activated NPBP-plasmin complex 
(also possibly protected from inactivation by cz-2 antiplasmin) 
is  thus  capable of activation  of the  complement  cascade, 
chemotaxis,  and hydrolysis of connective tissues and base- 
ment membranes,  all prime features of acute inflammation 
in APSBN. The fact that this plasmin binding protein is in 
reality an SPEB precursor raises  the question as to whether 
the protease activity and/or its superantigen properties might 
also contribute to the inflammatory damage seen in APSGN. 
Schlievert et al. (16) noted that nephritogenic group A iso- 
lates consistently produced SPEB either alone or in combina- 
tion with the other two characterized pyrogenic exotoxins 
(SPEA and SPEC). These data emphasize the need to further 
investigate  this  toxin's contribution  to nephritis. 
Whether or not this secreted plasmin binding protein ei- 
ther alone or within circulating complexes of these patients 
is also localized in the glomeruli of APSGN patients and has 
particularly affinity for certain receptors in glomerular tissue 
is currently under investigation. 
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